Research
433 articles
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.
Making Surgery An Option for More Pancreatic Cancer Patients
Dr. John Chabot explains that more pancreatic cancer patients may qualify for surgery if they consult an experience pancreatic surgical team.
Adjuvant Chemotherapy with Modified FOLFIRINOX Regimen Improves Survival
A French clinical trial showed that adjuvant chemotherapy (given after surgery) with modified FOLFIRINOX improves survival of pancreatic cancer patients.
Can a Pancreatic Cancer Screening Test Become a Reality?
Dr. Felice Schnoll-Sussman discusses screening options for pancreatic cancer and criteria for people who might want to get screened.
Chemotherapy Regimen for Post-Surgery PNET Patients
Will a chemotherapy combination be effective against PNET after high-grade tumors are surgically removed? A clinical trial takes a closer look.
A New Immunotherapy Drug to Make Chemotherapy More Effective for Metastatic Pancreatic Cancer
Researchers are testing a new immunotherapy drug to make standard chemotherapy more effective for metastatic pancreatic cancer.
Leveraging Nanoparticle Technology for Paclitaxel Delivery in Pancreatic Cancer Patients
Dr. Allyson Ocean explains why nanoparticle delivery technology for getting paclitaxel to the tumor could be advantageous for patients.
Using a Colon Cancer Drug to Treat Advanced Pancreatic Cancer
A clinical trial tests the effectiveness of an approved colon cancer drug against advanced pancreatic neuroendocrine cancer.
Have Hope
Andy Seynaeve has undergone many rounds of chemotherapy but he has had a great response. Best of all, he has hope.
Practicing Gratitude Every Day
The best thing Chris Joseph ever did was change oncologists. His new doctor did genetic testing on Chris’s tumor, for better treatment.
Relocating For Pancreatic Cancer Treatment and a Clinical Trial
Rachel Moreno knew she would need help during treatment but moving in with her son also gave her access to a clinical trial.
Surviving and Thriving
When long-term survivor Chris Joseph found out his tumor had a specific defect it changed his treatment plan.
You Can Win This Fight
Rachel Moreno credits long-term survivor status to her choice to move to her son’s in Michigan for treatment, where she found a doctor and a clinical trial.